6505--Clobetasol Cream and Ointment (VA-25-00041429)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79725R0040
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Nicholas McGregor nicholas.mcgregor@va.gov (708) 786-4934
- Ray Roldan raymond.roldan@va.gov (708) 786-4930
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is seeking to procure Clobetasol Propionate 0.05% Topical Cream and Ointment for VA, DoD, Bureau of Prisons, and Indian Health Service pharmaceutical programs. The solicitation (36E79725R0040) is structured to establish a contract for two product groups: Group I (Cream) and Group II (Ointment), with package sizes ranging from 15 to 60 grams. Offerors must submit pricing for a base year and four additional one-year option periods, include a 0.5% Cost Recovery Fee, and provide a unique 11-digit National Drug Code (NDC) number for each product. The evaluation will be conducted using lowest price technically acceptable criteria, with technical acceptability determined by FDA approval, manufacturing facility requirements, and compliance with specified product descriptions. Proposals are due by June 17, 2025, at 2:30 PM Central Daylight Time, with the solicitation originally issued on May 22, 2025.
The solicitation does not have a specific small business set-aside, with a small business size standard of 1,300 employees. The estimated annual quantities range from approximately 19,351 to 130,598 tubes per line item, indicating a significant procurement volume. The government reserves the option to award two separate contracts (one for each product group) or a single contract covering both groups. The contract will support multiple federal agencies, with potential performance locations likely spread across various VA, DoD, Bureau of Prisons, and Indian Health Service facilities nationwide. While specific award values are not explicitly stated, the multi-year contract structure and substantial annual quantity suggest a potentially high-value procurement opportunity for pharmaceutical manufacturers meeting the technical and compliance requirements.
Notice text
2 versions
Update #2 · Latest ·
Extend the due date and time for receipt of offers. See Amendment document for details.
Update #1 ·
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0040 0001.docx | DOCX document | |
| 36E79725R0040.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Clobetasol Cream and Ointment Encube Ethicals, Inc. Base Ordering Period 11/17/2025 - 11/16/2026 | Award Notice | |
| This notice | Solicitation | |
| 6505--Clobetasol Cream and Ointment (VA-25-00041429) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Lidocaine 5% patches-request for information | Veterans Integrated Service Network 15 | No set-aside | |
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | National Acquisition Center | No set-aside | |
| 6505--Ramipril Capsules RFP | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity